IRIS
MONDA, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.161
AS - Asia 1.739
NA - Nord America 1.042
SA - Sud America 291
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.256
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.496
US - Stati Uniti d'America 997
SG - Singapore 675
CN - Cina 433
BR - Brasile 240
HK - Hong Kong 228
IT - Italia 199
IE - Irlanda 191
VN - Vietnam 130
DE - Germania 118
KR - Corea 109
IN - India 73
GB - Regno Unito 30
FI - Finlandia 26
JP - Giappone 26
AR - Argentina 24
FR - Francia 23
MX - Messico 19
AT - Austria 18
CA - Canada 18
EC - Ecuador 15
BD - Bangladesh 14
TR - Turchia 9
PL - Polonia 8
CH - Svizzera 7
IQ - Iraq 7
NL - Olanda 7
ZA - Sudafrica 7
LT - Lituania 6
MA - Marocco 6
SE - Svezia 6
ID - Indonesia 5
CO - Colombia 4
CZ - Repubblica Ceca 4
ES - Italia 4
NP - Nepal 4
PK - Pakistan 4
EG - Egitto 3
JM - Giamaica 3
JO - Giordania 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
LB - Libano 2
LK - Sri Lanka 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BW - Botswana 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
RO - Romania 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.256
Salva come PNG Salva come JPEG
Città #
Moscow 1.283
Santa Clara 286
Singapore 267
Hong Kong 228
Dublin 191
Hefei 140
Chandler 126
Seoul 109
New York 81
Naples 56
Ashburn 54
Bengaluru 51
Ho Chi Minh City 51
Munich 44
Beijing 43
The Dalles 31
Hanoi 27
Bremen 21
Cambridge 21
Princeton 21
Roxbury 21
Los Angeles 20
São Paulo 20
Turku 18
Rome 17
Dallas 15
Falkenstein 15
Nuremberg 15
Frankfurt am Main 10
Chicago 9
Hyderabad 9
Marano Di Napoli 9
Toronto 9
Vienna 9
Belo Horizonte 7
Boardman 7
Brasília 7
Dhaka 7
Guangzhou 7
Milan 7
Salvador 7
Amsterdam 6
Atlanta 6
Brooklyn 6
Caserta 6
Da Nang 6
Guayaquil 6
London 6
Stockholm 6
Chennai 5
Haiphong 5
Lappeenranta 5
Pratteln 5
Rio de Janeiro 5
Baghdad 4
Biên Hòa 4
Boston 4
Buenos Aires 4
Changsha 4
Contagem 4
Denver 4
Des Moines 4
Johannesburg 4
Marcianise 4
Napoli 4
Newark 4
Ninh Bình 4
Porto Alegre 4
Quito 4
Tokyo 4
Warsaw 4
Amman 3
Aversa 3
Benito Juarez 3
Bexley 3
Boone 3
Brdo 3
Bắc Ninh 3
Cairo 3
Canoas 3
Casalnuovo di Napoli 3
Curitiba 3
Fortaleza 3
Goiânia 3
Guarulhos 3
Helsinki 3
Manassas 3
Mexico City 3
Ottawa 3
Pozzuoli 3
San Francisco 3
Seattle 3
Shanghai 3
Vicenza 3
Wilmington 3
Alghero 2
Andradina 2
Anápolis 2
Augusta 2
Barbianello 2
Totale 3.599
Salva come PNG Salva come JPEG
Nome #
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 180
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 155
Advanced Heart Failure in Special Population—Pediatric Age 153
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 141
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 138
Natural history of left ventricular hypertrophy in infants of diabetic mothers 138
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 137
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia 136
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes 133
Combined Clinical, Molecular, and Muscle Biopsy Approach to Unveil Prevalence and Clinical Features of Rare Neuromuscular and Mitochondrial Diseases in Patients With Cardiomyopathies 128
Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes 127
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 127
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies 124
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 123
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 120
Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) 118
An atypical Aymé-Gripp phenotype detected by exome sequencing 117
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy 116
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 114
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 112
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines 111
Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management 111
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 111
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 110
Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy 109
External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis 104
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go 103
A complex unit for a complex disease: The HCM-Family Unit 103
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 102
Global left ventricular myocardial work efficiency in heart failure patients with cardiac amyloidosis: Pathophysiological implications and role in differential diagnosis 100
Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy 99
Effectiveness in the short-term of a novel nutraceutical for the management of hypercholesterolemia: an observational multicenter primary care experience 98
Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria 93
Prevalence and direct costs of patients with neuromyelitis optica: Data from Campania region in southern Italy 93
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update 92
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis 92
Amyloid Cardiomyopathies: Clinical, Diagnostic, and Therapeutic Aspects 92
Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine 91
Clinical pathway on pediatric cardiomyopathies: A genetic testing strategy proposed by the Italian Society of Pediatric Cardiology 91
Thoracic Aortic Dilation: Implications for Physical Activity and Sport Participation 90
Resistive index of central retinal artery, aortic arterial stiffness and OCTA correlated parameters in the early stage of fabry disease 90
Patterns of Left Ventricular Remodelling in Children and Young Patients with Hypertrophic Cardiomyopathy 89
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis 88
Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation 86
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes 85
Clinical manifestation of patients with Fabry disease and R356W GLA variant 85
Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference 84
Prevalence and Clinical Significance of Intraventricular Conduction Disturbances in Hospitalized Children 84
An Overview of Molecular Mechanisms in Fabry Disease 83
A Roadmap to Predict Adverse Outcome in Fabry Disease 82
Athlete’s Heart: A Cardiovascular Step-By-Step Multimodality Approach 81
Genetic evaluation in athletes and cascade family screening: reply 81
Left ventricular rotational mechanics in cardiac amyloidosis - reply 79
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 78
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis 77
The role of genetic testing in Marfan syndrome 77
Current Management of Transition and Multidisciplinary Care of Patients with Inherited and Rare Cardiomyopathies in Europe: Results of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART) 76
Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure 72
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine 71
Is There a Role for Genetic Testing in Patients With Myocarditis? 70
Editorial: Paediatric Cardiomyopathies 70
Prediction of radial crossover in acute coronary syndromes: Derivation and validation of the MATRIX score 70
Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives 69
From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow 69
Sport activity in patients with cardiomyopathies: a review 67
Integrated Sudden Cardiac Death Risk Prediction Model For Patients With Hypertrophic Cardiomyopathy 63
Letter by Monda and Limongelli Regarding Article, "The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy" 62
The heart in RASopathies 61
Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes 61
The Prognostic Role of Pulmonary Arterial Elastance in Patients Undergoing Left Ventricular Assist Device Implantation: A Pilot Study 60
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease 58
Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice 56
Sudden cardiac death risk prediction in Fabry disease: How many strings do we have on our bow? 55
Editorial: Cardiovascular genetics-focus on paediatric cardiomyopathy 54
Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease 53
Heart failure with preserved ejection fraction: the need for a better genetic characterization 52
Letter by Monda and Limongelli Regarding Article, “Changes in Cardiac Function Following Fulminant Myocarditis” 50
Expanding the knowledge on transthyretin p.V142I variant-related cardiomyopathy 50
The Italian Fabry Disease Cardiovascular Registry (IFDCR) 39
Cardiovascular Morbidity and Mortality in Fabry Disease 12
Totale 7.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.878
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022147 9 3 2 0 30 9 9 8 6 9 11 51
2022/2023422 38 38 6 24 49 29 3 22 182 5 14 12
2023/2024358 15 11 12 24 59 91 13 34 9 10 16 64
2024/20251.367 4 8 2 30 260 187 160 120 220 130 138 108
2025/20265.087 317 383 317 242 507 3.321 0 0 0 0 0 0
Totale 7.381